Submissions

Login or Register to make a submission.

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.
  • The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in Comments to the Editor).
  • The submission file is in Microsoft Word document file format.
  • Where available, URLs for the references have been provided.
  • The text is double-spaced; uses a 12-point font; employs italics, rather than underlining (except with URL addresses); and all illustrations, figures, and tables are placed within the text at the appropriate points, rather than at the end.
  • The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines, which is found in About the Journal.
  • If submitting to a peer-reviewed section of the journal, the instructions in Ensuring a Blind Review have been followed.
  • Statement on conflict of interst has been declared.

Author Guidelines

Author Guidelines
The Journal of Medicine (www.banglajol.info/index.php/JOM/index) publishes original papers, reviews concerned with recent practice and case reports of exceptional merit. The Journal considers manuscripts prepared in accordance with the guidelines laid down by the International Committee of Medical Journal Editors (www.icmje.org/index.html). A covering letter signed by all authors must state that the data have not been published elsewhere in whole or in part and all authors agree their publication in Journal of Medicine. If the work has been conducted abroad then the article must be accompanied by certificate from the Head of the institute where the work has been done. The editor & editorial board do not subscribe to the views expressed in the article written by the author or authors published in this journal.

The editorial board reserves the right to edit and if necessary, shorten any material accepted for publication. The decision on the priority of publication would be strictly determined by the editorial board. All manuscript will go through a double-blind peer review process.

Manuscripts may be submitted electronically via online submission system by registering online and selecting the role of an Author.

Alternatively, manuscript may be submitted in the following manner:

TYPE SCRIPTS:
Three typed copies of the article and one copy on a CD-ROM processed in MS Word(*.doc format only) should be submitted to the Editor. British English is preferred. The text should be type-written in 12-point font Times New Roman, double spaced on one side of the paper not larger than ISO A4 (210× 297 mm) with a 5 cm margin and paper should be numbered consecutively. The first page of the type script should bear the names of the author(s) and the name and address of the institution or laboratory where the work has been carried out, in addition to the title of the paper. The full address of the principal author to whom proofs will be sent should be given as footnote, as should any permanent change of address and/or appointment. Correspondence should also include e-mail address. A short (running) title of not more than 45 characters should be given. Please write as concisely as possible. Amendments should be made in the texts and not in the margins. All submitted manuscripts are reviewed by the editors and rejected manuscripts will not be returned. Ethical aspects will be considered in the assessment of the paper.

ARRANGEMENT:
Papers should be divided into: (a) Title page (b) Abstract (c) Introduction (d) Materials and methods (e) Results (f) Discussion (g) Acknowledgement (h) Reference (i) Tables (j) Figures and Captions. The Abstract should not exceed 250 words and should state concisely what was done, the main findings and how the work was interpreted. Following abstract, mention three to five keywords relevant to the article.

STYLE:
Abbreviations and symbols must be standard and SI units should be used throughout. Whenever possible, drugs should be given their approved generic name. Acronyms should be used sparingly. Statistical analysis must explain the methods used. Reference should follow the Vancouver format. In the text, they should appear as numbers starting at 1. At the end of the paper they should be listed (double spaced) in numerical order corresponding to the orders of citation in the text. All authors should be quoted for papers with up to six authors, for papers with more than six authors the first six only should be quoted followed by et al. Abbreviations for titles of medical periodicals should conform to those used in the latest edition of Index Medicus (found at www.ncbi.nlm.nih.gov/journals?itool=sidebar). The first and last page numbers for each reference should be provided. Abstracts and letter must be identified as such. Authors must check references against original sources for accuracy. Examples of reference are given below:

Articles in journals:

  1. Paganini Hill A, Chao A, Ross Rk, Henderson BE. Aspirin use and chronic disease: a cohort study of the elderly. BMJ 1989; 299: 1247-50.
  2. Parkin DM, Clayton D, Blook RJ, Massyer E, Fried HP, Iranov E, et al. Childhood Leukaemia in Europe after Chernobyl : 5 years follow-up. Br J Cancer 1996; 73: 1006-12.

Chapter in a book:

  1. Phyllyps SJ, Whisnant JP. Hypertension and Stroke. In: Lurgh JH, Brennes BM, editors. Hypertension : Pathophysiology, diagnosis and management. 2nd ed. New York : Raven Press; 1995. p. 465-78.

Tables should be as few as possible and should present only essential data. Each table should be type-written on separate sheets, have a title or caption with Roman numbers. All photographs, graphs, diagrams should be referred to as figures and should be numbered consecutively in the text in Arabic numerical. The legends for illustrations should be typed on separate sheets. All illustration must be in JPEG format at a resolution of 300 dots/inch (DPI) or higher. A separate file should be submitted for each Figure or Figure part. Photomicrographs should be un- mounted glossy prints. Photomicrographs should have internal scale markers; include in the legend the original magnification and the stain used. Line diagrams and graphs should be scanned at 600 DPI (or better) and submitted on separate sheets. The editorial board reserves the right to crop/trim any illustration to conform to the style of the text. Subject/patient must not be identifiable on the photograph. If this is unavoidable, written permission from the patient or legal guardian must be obtained.

PROOFS:
Two marked copies of the proofs may be sent to the principle author which should be read carefully for error. One corrected copy must be returned to the editor within the next three days. Major alteration in the text cannot be accepted.

For author instructions on individual article type please visit the Section Policies of the journal.

EDITORIAL MAIL:
Manuscripts and other communication for the editors should be addressed to

Editor-in-Chief

Journal of Medicine 
Dhaka, Bangladesh

editorjom@yahoo.com

Original Articles

Original article may be of following types: observational study, randomised controlled trial, systematic review or meta-analysis, retrospective clinical analysis, laboratory research and related studies. All original articles must carry a structured abstract not exceeding 250 words. The word limit for this type of article is 1000 to 1500 excluding tables, figures or references. This may be extended at the discretion of the editor(s). 

All studies involving human must include a statement in the Materials and Methods section that the study has been approved by the institutional research ethics committee or the institutional review board. Signed written informed consent by the participants must also be submitted.

The authors are strongly encouraged to submit following additional completed checklist:

1. STROBE checklist for an observational study.

2. CONSORT checklist for a randomised controlled trial.

3. PRISMA checklist and flowchart for a systematic review or meta-analysis of randomised trials

4. MOOSE checklist and flowchart for a meta-analysis of observational studies.

Review Articles

1. Review articles should focus on topics particularly relevant to Bangladesh.

2. Extensive search of published literature through databases like MEDLINE or EMBASE should be performed and the method applied should be discussed in short in the manuscript.

3. Word limit for this section is 1500 words.

4. A non-structured abstract should be included

5. Number of references should be proportionate to the length of the article (preferably below 25).

6. The editor may also solicit review from experts of their respective fields.

Clinical Image

Author Instuctions

1. Submitted image(s) must be authentic. The editor may ask for hard copy of the images, if necessary.

2. Images should be interesting, classic or extraordinary.

3. Clinical Images are not meant to be replacement for case report.

4. High-resolution images accompanied by appropriate label and figure caption are required.

5. Images must not be scanned. Images and description should be submitted separately.

6. A brief explanation (200 words maximum) of the images containing short description of the patient's history, physical and laboratory findings, clinical outcome, response to treatment (if any), and condition at last follow-up is required.

7. Number of references (Vancouver style) should not exceed 2(two).

8. Number of authors should not exceed 4(four).

9. The submission must be accompanied by the patient's written consent for publication.

Case Reports

1. Case report may carry description of cases of unusual presentation of common diseases, previously unknown or less known diseases, hard-to-find observation of common diseases, cases with important message to the readers.

2. Word limit for case report is 500 to 750 words.

3. All case reports should include a non-structured abstracts.

4. Number of references should be proportionate to the topic presented (preferably below 15).

5. Number of figures and tables should not exceed 2 (two) each (exceptions may be allowed in some instances).

6. High resolution images must be submitted. Images should not be scanned.

7. Depending on the quality and message of the manuscript and at the discretion of the editor, some case reports may be assigned to the Clinical Image or Letter to Editor section of the journal.

Privacy Statement

Bangladesh Journals Online (BanglaJOL) is a member of the Ubiquity Partner Network coordinated by Ubiquity Press. According to the EU definitions, BanglaJOL is the data controller, and Ubiquity Press are the service providers and data processors. Ubiquity Press provide the technical platform and some publishing services to BanglaJOL and operate under the principle of data minimisation where only the minimal amount of personal data that is required to carry out a task is obtained.

More information on the type of data that is required can be found in Ubiquity Press’ privacy policy below.

Ubiquity Press Privacy Policy

We take seriously our duty to process your personal data in a fair and transparent way. We collect and manage user data according to the following Privacy Policy. This document is part of our Terms of Service, and by using the press portal, affiliated journals, book, conference and repository websites (the “Websites”), you agree to the terms of this Privacy Policy and the Terms of Service. Please read the Terms of Service in their entirety, and refer to those for definitions and contacts.

What type of personal data do we handle?

There are four main categories of personal data stored by our journal platform, our press platform, and our book management system; Website User data, Author data, Reviewer data and Editor data.

The minimum personal data that are stored are:

  • full name
  • email address
  • affiliation (department, and institution)
  • country of residence

Optionally, the user can provide:

  • salutation
  • gender
  • associated URL
  • phone number
  • fax number
  • reviewing interests
  • mailing address
  • ORCiD
  • a short biography
  • interests
  • Twitter profile
  • LinkedIn profile
  • ImpactStory profile
  • profile picture

The data subjects have complete control of this data through their profile, and can request for it to be removed by contacting info@ubiquitypress.com

What do we do to keep that data secure?

We regularly backup our databases, and we use reliable cloud service providers (Amazon, Google Cloud, Linode) to ensure they are kept securely. Backups are regularly rotated and the old data is permanently deleted. We have a clear internal data handling policy, restricting access to the data and backups to key employees only. In case of a data breach, we will report the breach to the affected users, and to the press/journal contacts within 72 hours.

How do we use the data?

Personal information is only used to deliver the services provided by the publisher. Personal data is not shared externally except for author names, affiliations, emails, and links to ORCiD and social media accounts (if provided) in published articles and books which are displayed as part of the article/book and shared externally to indexes and databases. If a journal operates under open peer review then the reviewer details are published alongside the reviewer details.

How we collect and use your data:

1. When using the website

1.1 what data we collect

  • When you browse our website, we collect anonymised data about your use of the website; for example, we collect information about which pages you view, which files you download, what browser you are using, and when you were using the site.
  • When you comment on an article or book using Disqus, we are not collecting, controlling or processing the data. More details on the DISQUS privacy policy can be found on their website.
  • When you annotate an article or book, this is done via a 3rd party plugin to the website called Hypothes.is. In using this plugin we are not collecting, controlling or processing the data. More details on the Hypothes.is privacy policy can be found on their website.

1.2 why we collect the data

  • We use anonymised website usage data to monitor traffic, help fix bugs, and see overall patterns that inform future redesigns of the website, and provide reports on how frequently the publications on our site have been accessed from within their IP ranges.

1.3 what we do (and don’t do) with the data

  • We do not collect personal information that can be used to identify you when you browse the website.
  • We currently use Google Analytics for publication reports, and to improve the website and services through traffic analysis, but no personal identifying data is shared with Google (for example your computer’s IP is anonymised before transmission).

1.4 what to do if you want to get a copy of your data, or want your data to be removed

  • Please contact info@ubiquitypress.com to request a copy of your data, or for your data to be removed/anonymised.

2. When registering as an author, and submitting an article or book

2.1 what data we collect

  • When registering an account we ask you to log in and provide certain personal information (such as your name and email address), and there is the option to register using an ORCiD which will pre-fill the registration form.
  • As part of submitting an article for publication, you will need to provide personally identifying information which will be used for the peer review process, and will be published. This can include ‘Affiliation’, ‘Competing interests’, ‘Acknowledgements’.

2.2 why we collect the data

  • Registering an account allows you to log in, manage your profile, and participate as an author/reviewer/editor. We use cookies and session information to streamline your use of the website (for example in order for you to remain logged-in when you return to a journal). You can block or delete cookies and still be able to use the websites, although if you do you will then need to enter your username and password to login. In order to take advantage of certain features of the websites, you may also choose to provide us with other personal information, such as your ORCiD, but your decision to utilize these features and provide such data will always be voluntary.
  • Personal data submitted with the article or book is collected to allow follow good publication ethics during the review process, and will form part of the official published record in order for the provenance of the work to be established, and for the work to be correctly attributed.

2.3 what we do (and don’t do) with the data

  • We do not share your personal information with third parties, other than as part of providing the publishing service.
  • As a registered author in the system you may be contacted by the journal editor to submit another article.
  • Any books published on the platform are freely available to download from the publisher website in PDF, EPUB and MOBI formats on the publisher’s site.
  • Any personal data accompanying an article or a book (that will have been added by the submitting author) is published alongside it. The published data includes the names, affiliations and email addresses of all authors.
  • Any articles published on the platform are freely available to download from the publisher website in various formats (e.g. PDF, XML).
  • Ubiquity Press books and articles are typeset by SiliconChips and Diacritech.This process involves them receiving the book and book associated metadata and contacting the authors to finalise the layout. Ubiquity Press work with these suppliers to ensure that personal data is only used for the purposes of typesetting and proofing.
  • For physical purchases of books on the platform Ubiquity Press use print on demand services via Lightning Source who are responsible for printing and distribution via retailers. (For example; Amazon, Book Repository, Waterstones). Lightning Source’s privacy policy and details on data handling can be found on their website.

2.4 why we store the data

  • We store the account data so that you may choose to become a reviewer and be able to perform those tasks, or to become an author and submit an article and then track progress of that article.
  • Published personal data that accompanies an article or a book forms part of the official published record in order for the provenance of the work to be established, and for the work to be correctly attributed.

2.5 what to do if you want to get a copy of your data, or want your data to be removed

  • You are able to view, change and remove your data associated with your profile. Should you choose to completely delete your account, please contact us at support@ubiquitypress.com and we will follow up with your request as soon as possible.
  • To conform to publication ethics and best practice any personal data that is published alongside an article or book cannot be removed. If you have a query about a publication to which you are attributed please contact info@ubiquitypress.com

3. When registering as a reviewer

3.1 what data we collect

  • To become a reviewer you must first register as a user on the website, and set your preference that you would like to be considered as a reviewer. No new personal data is collected when a registered user elects to become a reviewer.
  • When registering an account we ask you to log in and provide certain personal information (such as your name and email address), and there is the option to register using an ORCiD which will pre-fill the registration form.
  • Reviewers can also be registered by editors who invite them to review a specific article. This requires the editor to provide the reviewer’s First Name, Last Name, and Email address. Normally this will be done as part of the process of inviting you to review the article or book.
  • On submitting a review, the reviewer includes a competing interest statement, they may answer questions about the quality of the article, and they will submit their recommendation.

3.2 why we collect the data

  • The data entered is used to invite the reviewer to peer review the article or book, and to contact the reviewer during and the review process.
  • If you submit a review then the details of your review, including your recommendation, your responses to any review form, your free-form responses, your competing interests statement, and any cover letter are recorded.

3.3 what we do (and don’t do) with the data

  • This data is not shared publicly and is only accessible by the Editor and system administrators of that journal or press.
  • The data will only be used in connection with that journal or press.
  • Data that is retained post final decision is kept to conform to publication ethics and best practice, to provide evidence of peer review, and to resolve any disputes relating to the peer review of the article or book.
  • For journals or presses that publish the peer reviews, you will be asked to give consent to your review being published, and a subset of the data you have submitted will become part of the published record.

3.4 what to do if you want to get a copy of your data, or want your data to be removed

  • If you would no longer like to be registered as a reviewer you can edit your profile and tick the box ‘stop being a reviewer’. This will remove you from the reviewer database, however any existing reviews you may have carried out will remain.
  • If you have been contacted by an editor to peer review an article this means that you have been registered in the system. If you would not like to be contacted for peer review you can reply to the email requesting that your data be deleted.

4. When being registered as a co-author

4.1 what data we collect

  • Co-author data is entered by the submitting author. The submitting author will already have a user account. According to standard publishing practice, the submitting author is responsible for obtaining the consent of their co-authors to be included (including having their personal data included) in the article/book being submitted to the journal/press.
  • The requested personal data for co-authors are at the bare minimum; first name, last name, institution, country, email address. This can also include; ORCID ID, Title, Middle Name, Biographical Statement, Department, Twitter Handle, Linkedin Profile Name or ImpactStory ID.

4.2 why we collect the data

  • Assuming that it is accepted for publication, this data forms part of the official published record in order for the provenance of the work to be established, and for the work to be correctly attributed.
  • Author names, affiliations and emails are required for publication and will become part of the permanent cited record.

4.3 what we do (and don’t do) with the data

  • The co-author’s personal data is stored in the author database. This personal data is only used in relation to the publication of the associated article.
  • Any co-author data collected is added to the author database and is only used in association with the article the user is co-author on.

4.5 what to do if you want to get a copy of your data, or want your data to be removed

  • To receive a copy of your data, please contact info@ubiquitypress.com
  • To conform to publication ethics and best practice any personal data that is published alongside an article or book cannot be removed. If you have a query about a publication to which you are attributed please contact info@ubiquitypress.com

5. When signing-up to receive newsletters

5.1 what data we collect

  • We require you to include your name and email address

5.2 why we collect and store the data, and for how long

  • This data would be collected to keep you updated with any news about the platform or specific journal

5.3 what we do (and don’t do) with the data

  • We use mailchimp to provide our mailing list services. Their privacy policy can be found here

5.4 what to do if you want to get a copy of your data or want your data to be removed

  • All emails sent via our newsletter client will include a link that will allow you to unsubscribe from the mailing list

Notification about change of ownership or of control of data

We may choose to buy or sell assets. In the case that control of data changes to or from Ubiquity Press and a third party, or in the case of change of ownership of Ubiquity Press or of part of the business where the control of personal data is transferred, we will do our best to inform all affected users and present the options.

(Updated: 18 May 2018)